ConductScience.org, home

Paper12374678

A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.

Fabian CJ and 12 others. Clin Cancer Res, 2002. Cited by 86 papers, by iCite.

Cite this record

ConductScience Library. A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers. Papers, record 12374678. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12374678

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.
PubMed
Journal
Clin Cancer Res
PubMed
Year
2002
PubMed
Publication types
Clinical Trial, Clinical Trial, Phase II, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
2.04
iCite
Revised in PubMed
2018-11-30
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fabian CJCarol J
2Kimler BFBruce F
3Brady DADeborah A
4Mayo MSMatthew S
5Chang CHC H Joseph
6Ferraro JAJohn A
7Zalles CMCarola M
8Stanton ALAnnette L
9Masood SShahla
10Grizzle WEWilliam E
11Boyd NFNorman F
12Arneson DWDora W
13Johnson KAKaren A

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Biomarkers, TumorMajor topic
Breast NeoplasmsMajor topic
EflornithineMajor topic
Enzyme InhibitorsMajor topic
PolyaminesMajor topic
Administration, Oral
Biopsy, Needle
Double-Blind Method
ErbB Receptors
Female
Hormones
Humans
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor I
Mammography
Middle Aged
Neoplasm Staging
Proliferating Cell Nuclear Antigen
Quality of Life
Tumor Suppressor Protein p53

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N01-CN-65124NCI NIH HHSUnited StatesN01CN065124PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
38943056Early detection of breast cancer through the diagnosis of Nipple Aspirate Fluid (NAF).Clin Proteomics2024https://conductscience.org/library/papers/38943056PubMed
37795002Short-Term Biomarker Modulation Study of Dasatinib for Estrogen Receptor-Negative Breast Cancer Chemoprevention.Eur J Breast Health2023https://conductscience.org/library/papers/37795002PubMed
35620919Ototoxicity of Long-Term α-Difluoromethylornithine for Skin Cancer Prevention.Laryngoscope2023https://conductscience.org/library/papers/35620919PubMed
34067619Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.Biomolecules2021https://conductscience.org/library/papers/34067619PubMed
33669273Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro.Viruses2021https://conductscience.org/library/papers/33669273PubMed
32139506Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy.J Biol Chem2020https://conductscience.org/library/papers/32139506PubMed
31052199Coxsackievirus B3 Responds to Polyamine Depletion via Enhancement of 2A and 3C Protease Activity.Viruses2019https://conductscience.org/library/papers/31052199PubMed
31043534Polyamine Depletion Inhibits Bunyavirus Infection via Generation of Noninfectious Interfering Virions.J Virol2019https://conductscience.org/library/papers/31043534PubMed
29533973Cellular and Animal Model Studies on the Growth Inhibitory Effects of Polyamine Analogues on Breast Cancer.Med Sci (Basel)2018https://conductscience.org/library/papers/29533973PubMed
29344009Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer.Clin Proteomics2018https://conductscience.org/library/papers/29344009PubMed
27261491Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk.Cancer Prev Res (Phila)2016https://conductscience.org/library/papers/27261491PubMed
25031974Random periareolar fine-needle aspiration: the new pap smear of the breast?J Adv Pract Oncol2012https://conductscience.org/library/papers/25031974PubMed
24166281A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.Breast Cancer Res Treat2013https://conductscience.org/library/papers/24166281PubMed
23221207Difluoromethylornithine: the proof is in the polyamines.Cancer Prev Res (Phila)2012https://conductscience.org/library/papers/23221207PubMed
23181218Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma.Front Oncol2012https://conductscience.org/library/papers/23181218PubMed
22924092Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer.Curr Breast Cancer Rep2012https://conductscience.org/library/papers/22924092PubMed
22122766DFMO: targeted risk reduction therapy for colorectal neoplasia.Best Pract Res Clin Gastroenterol2011https://conductscience.org/library/papers/22122766PubMed
21647677Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.Breast Cancer Res Treat2012https://conductscience.org/library/papers/21647677PubMed
20816506Phase II cancer prevention clinical trials.Semin Oncol2010https://conductscience.org/library/papers/20816506PubMed
20051371A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.Cancer Prev Res (Phila)2010https://conductscience.org/library/papers/20051371PubMed

See all 34 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
IGFBP33486PubTator's text mininghttps://conductscience.org/library/genes/3486NCBI Gene
ODC14953PubTator's text mininghttps://conductscience.org/library/genes/4953NCBI Gene
PCNA5111PubTator's text mininghttps://conductscience.org/library/genes/5111NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12374678

GET https://conductscience.org/api/papers/v1/12374678/cited_by?page=2